Literature DB >> 4831316

Spectrum of hyperparathyroidism.

E Reiss, J M Canterbury.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4831316     DOI: 10.1016/0002-9343(74)90807-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  7 in total

1.  Bone remodeling in chronic renal failure in perinatally irradiated beagles.

Authors:  F Villafañe; R W Norrdin; C A Lopresti; D Kimmel
Journal:  Calcif Tissue Res       Date:  1977-06-28

2.  [A family with multiple endocrine adenomatosis (MEA Type I) and some additional peculiarities alpha-1-antitrypsin deficiency (twice), polyp of small intestine with heterotopic gastric mucosa (once), medullary thyroid carcinoma (once) (author's transl)].

Authors:  F Eberle; C Assmus; G A Martini
Journal:  Klin Wochenschr       Date:  1979-05-16

3.  Immunoheterogeneity of parathyroid hormone in venous effluent serum from hyperfunctioning parathyroid glands.

Authors:  J A Flueck; F P Di Bella; A J Edis; J M Kehrwald; C D Arnaud
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

4.  Responsiveness of neoplastic and hyperplastic parathyroid tissues to calcium in vitro.

Authors:  J F Habener
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

5.  Radicular lower extremity pain as the first symptom of primary hyperparathyroidism.

Authors:  Antti O T Mustonen; Martti J Kiuru; Anders Stahls; Tom Bohling; Aarne Kivioja; Seppo K Koskinen
Journal:  Skeletal Radiol       Date:  2004-06-19       Impact factor: 2.199

6.  [Hyperparathyroidism in hemodialysis patients: studies on parathyroid regulation and classification problems (author's transl)].

Authors:  R Augustin; W H Hackeng
Journal:  Klin Wochenschr       Date:  1981-11-16

7.  Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism.

Authors:  Béla Szende; Parvaneh Farid; Gyula Végso; Ferenc Perner; László Kopper
Journal:  Pathol Oncol Res       Date:  2004-06-09       Impact factor: 2.874

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.